Portfolio: Overview

DELIVERING VALUE FOR PATIENTS AND INVESTORS
Harnessing our unique investment approach focused on the translational stage of drug development, combined with our agile operating model for company formation and trial execution, Aditum Bio has launched thirteen companies to date and is currently deploying out of Fund III.